Category Archives: Cancer Survivors

Issels Out-Patient Apartments in Santa Barbara, California

There Truly is Nothing More Relaxing nor Refreshing than Focusing on Getting Better By the Beach.
There Truly is Nothing More Relaxing nor Refreshing than Focusing on Getting Better By the Beach.

Lifestyle and environment are two major factors that affect your health and well-being. When you receive out-patient immunotherapy for cancer at our Issels® Medical Center in Santa Barbara, relax and focus on healing with a stay at one of several charming apartments nearby.

Fully Furnished Ocean View Apartments

Issels® Medical Center is located in downtown Santa Barbara, with close proximity to shopping, restaurants and personal services. We’re pleased to offer our patients special rates on a number of exclusive, fully furnished one- and two-bedroom apartments in the area.

  • Enjoy ocean views and convenient direct access to the beach.
  • Upscale features include hardwood-style floors, ceiling fans, king-size beds and balconies and patios.
  • Each apartment has a generously sized, fully equipped gourmet kitchen.

The apartments are a perfect complement to our personally tailored immunotherapy for cancer programs. You’ll love returning from a treatment session to relax in luxurious and comfortable surroundings.

Additional Living Options

If you’re interested in other living arrangements, discounted rates are available at several suite-style hotels in the area that can accommodate any preferences. You can also choose from the variety of vacation rental apartments found throughout Santa Barbara.

Issels® Leads the Way in State-of-the-Art Immunotherapy for Cancer

At Issels®, you’re more than just a patient. Our caring and compassionate team is focused on every aspect of your healing and recovery.

Get first-hand accounts of why the Issels® difference makes us a leader in modern immunotherapy treatment. Visit our website to hear and read testimonials from patients of all ages and stages of cancer who have achieved long-term remission at Issels®.

John McCain and Glioblastoma

It's Time to Stop Cancer
It’s Time to Stop Cancer

Two years ago, then-Vice President Joe Biden was inspired by the death of his son to launch a “moonshot” campaign for cancer treatment research. Today, Sen. John McCain’s battle against brain cancer has once again turned a spotlight on the disease.

Vice-President Biden Joins the Fight Against Cancer

In May 2015, Biden’s eldest son Beau succumbed to glioblastoma, an aggressive form of brain cancer. The same disease claimed the late Sen. Edward Kennedy in 2009.

Four months after his son’s death, Biden called off his expected run for the presidency in order to launch a campaign of a different sort. Biden and his advisors joined forces with the American Association for Cancer Research to ramp up the search for a cure.

Brain Cancer Remains in Public Awareness

Arizona Sen. John McCain, a one-time Presidential candidate himself, was diagnosed with glioblastoma this past July. The diagnosis added another layer of drama when McCain returned to Washington, D.C. a week later and cast the deciding vote against a proposed repeal of the Affordable Care Act.

Last month, McCain appeared on CNN’s State of the Union to discuss his illness. The senator told host Jake Tapper that he would be undergoing an MRI the following day, adding that advancements in cancer treatment gave hope for his prognosis.

State-of-the-Art Immunotherapy from Issels®

Researchers have been making astounding breakthroughs in cancer treatment. Issels® has long been a leader in the use of personally tailored immunotherapy programs to successfully treat patients with all forms of cancer.

Contact us for more information about our integrative, non-toxic treatments such as cancer vaccines and NK cells.

Multiple Myeloma Patients React Positively to CAR T Cells Treatment

New Discoveries for Making Cancer Easier to Bear Are Sprouting Up!
New Discoveries for Making Cancer Easier to Bear Are Sprouting Up!

CAR T cells, engineered from a patient’s own immune cells, have proved to be a valuable weapon in immunotherapy cancer treatment. Now, recent trials demonstrate that CAR T cells may be effective against advanced multiple myeloma.

Global Testing of CAR T Cells

Earlier this year, two groups performed tests on CAR T cells designed to target B-cell maturation antigen (BCMA), a protein specific to myeloma.

  • Researchers in China conducted a study in which 33 of 35 patients went into complete remission within two months of treatment.
  • A team in Tennessee administered different doses of the CAR T cells to 21 patients. Beyond the first-level dose, patients experienced a 100 percent response rate, with 27 percent achieving a stringent complete response indicating no presence of the disease.

In another encouraging result, patients in both trials who experienced side effects were able to be successfully treated.

How CAR T Cells Fight Cancer

Unlike more traditional forms of cancer treatment, CAR T cells fall under the umbrella of immunotherapy. A patient’s individual immune cells are harvested from their blood, then engineered to target antigens, which are foreign bodies that trigger an immune response.

The CAR T cells are multiplied until they reach a quantity in the billions, then reintroduced into the patient. According to Dr. James Kochenderfer, lead author of the U.S. study, the key is targeting antigens that aren’t expressed in healthy tissues.

Immunotherapy at Issels®: State-of-the-Art Cancer Treatment

For decades, Issels® has been a leader in the healthcare community with our non-toxic, personally-tailored immunotherapy programs. Visit our website to hear success stories from patients with all forms of cancer.

New Blood Test May Identify Early Cases of Pancreatic Cancer

Tests Have Found Blood Can Help Identify Signs of Pancreatic Cancer.
Tests Have Found Blood Can Help Identify Signs of Pancreatic Cancer.

While pancreatic cancer is relatively rare in the United States, it’s one of the more deadly forms of the disease. According to a recently published study, a new blood test may be able to detect pancreatic cancer during its earliest and most treatable stages.

Solving the Puzzle of Early Detection

Experts predict that pancreatic cancer will become the second leading cause of cancer deaths by 2020. The main problem is late detection, with five-year survival rates coming in at less than 10 percent.

Scientists working on methods of early detection ran into a catch-22. Studies to identify potential markers relied on tumor samples from patients who were already in advanced stages of pancreatic cancer.

A Biomarker Breakthrough

The recent study was conducted by a joint University of Pennsylvania/Mayo Clinic team. Senior investigator Dr. Ken Zaret explained that reprogrammed cells were transplanted into mice, where they developed into invasive pancreatic tumors.

Samples from the lesions and tumors were then taken from the mice and used to identify proteins they secreted. Elevated levels of one protein, called THB52, was found to accurately distinguish between the affected and healthy controls, as well as between pancreatic cancer and other forms.

Dr. Zaret and his team are continuing their research with larger samples and more cross-validation. Researchers are hopeful that their work will lead to a viable test for people at high risk for pancreatic cancer.

Immunotherapy for Cancer at Issels®: Treatment for All Stages

We have used personalized immunotherapy for cancer programs to successfully treat patients with all forms of cancer in early and late stages. Contact us for more information.

What is Recurrent Cancer – What Do I Need to Know?

What Do I Need to Know?
What Do I Need to Know?

Have you ever heard stories about patients undergoing immunotherapy for cancer and experiencing no recurrence? Here’s what you need to know about recurrent cancer and what it means in terms of your overall health.

When Cancer Comes Back

Recurrence refers to cancer that returns after treatment has been completed. It originates with cancer cells that remained after the first course of treatment but were too small to show up in post-treatment testing.

Recurrent cancer is the same form as the original tumor, as opposed to a new type of cancer that may develop in patients who have a history of tumors. The latter is known as second primary cancer.

Types of Recurrent Cancer

Cancer recurs in three different ways:

• Local recurrence is in the same general area as the original tumor.

• Regional recurrence describes cancer that has grown into lymph nodes or other tissues near the original cancer.

• Distant recurrence is when cancer has spread to organs or other tissues far from the original site.

Another term that describes distant recurrence is metastatic cancer. Regardless of where the cancer has spread, it’s still the same type as the original tumor.

Testing and Treatment

Your doctor will likely repeat many of the same tests that resulted in the first diagnosis. These tests provide information to help determine the appropriate course of treatment.

Effective Non-Toxic Immunotherapy for Cancer at Issels®

The personally tailored immunotherapy for cancer treatments at Issels® are designed to boost your own immune system’s ability to recognize and destroy cancer cells. Contact us today to learn how our programs have helped patients achieve long-term remission.

Coaches vs. Cancer Has Raised $100 Million for Cancer Research

Coaches and Teams Have Raised Millions for Research
Coaches and Teams Have Raised Millions for Research

Actors, athletes and other high-profile people often use their celebrity to help promote awareness of cancer research. One such program is Coaches vs. Cancer, which has raised more than $100 million to support the American Cancer Society (ACS).

Leading the Charge Against Cancer

As with most Americans, basketball coaches across the country have been affected by cancer, either personally or through a loved one. The National Association of Basketball Coaches (NABC) has partnered with the ACS to form Coaches vs. Cancer, a program designed to empower the coaches to participate in the fight against cancer.

Coaches vs. Cancer: The “Battles”

Thanks to their personal and professional experiences and positions of leadership, basketball coaches are in a great position to raise awareness of cancer research among their teams and communities. Some of their creative initiatives have included:

  • In February 2017, their 3-Point Challenge let fans pledge an amount for every successful three-point shot made by their favorite team that month.
  • During Suits and Sneakers Week, coaches across the country wear sneakers on game day to symbolize the role of nutrition and physical activity in reducing cancer risk.
  • Hardwood Heroes is part of March Madness, the NCAA’s popular basketball championship tournament. 2017 marked the second year of this event in which a basketball team made up of cancer survivors took on a team of survivors from last year’s game.

Issels®: The Leader in Immunotherapy for Cancer Treatment

For decades, Issels® has raised the bar on cancer treatment with our non-toxic and integrative immunotherapy programs. Visit our website to read and hear testimonials from patients who have achieved long-term remission.